These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1357894)

  • 1. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans.
    Hansen K; Hovmark A; Lebech AM; Lebech K; Olsson I; Halkier-Sørensen L; Olsson E; Asbrink E
    Acta Derm Venereol; 1992 Aug; 72(4):297-300. PubMed ID: 1357894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and course of erythema chronicum migrans.
    Neumann R; Aberer E; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Feb; 263(3):372-6. PubMed ID: 3109145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Anaplasma phagocytophilum presence in early Lyme borreliosis manifested by erythema migrans skin lesions.
    Moniuszko-Malinowska A; Dunaj J; Andersson MO; Czupryna P; Zajkowska J; Guziejko K; Garkowski A; Grygorczuk S; Kondrusik M; Pancewicz S
    Travel Med Infect Dis; 2020; 36():101648. PubMed ID: 32247015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis.
    Weber K; Wilske B; Preac-Mursic V; Thurmayr R
    Infection; 1993; 21(6):367-72. PubMed ID: 8132365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of erythema migrans after treatment with phenoxymethyl penicillin.
    Bennet L; Danell S; Berglund J
    Scand J Infect Dis; 2003; 35(2):129-31. PubMed ID: 12693565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans.
    Arnez M; Radsel-Medvescek A; Pleterski-Rigler D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):916-22. PubMed ID: 10666802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease.
    Berger BW; Johnson RC
    J Am Acad Dermatol; 1989 Dec; 21(6):1188-91. PubMed ID: 2511231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.
    Breier F; Kunz G; Klade H; Stanek G; Aberer E
    Infection; 1996; 24(1):69-72. PubMed ID: 8852474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study.
    Nadelman RB; Nowakowski J; Forseter G; Bittker S; Cooper D; Goldberg N; McKenna D; Wormser GP
    Am J Med; 1993 Jun; 94(6):583-8. PubMed ID: 8506882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical manifestations, diagnosis and treatment of Lyme borreliosis].
    Ocias LF; Jensen BB; Knudtzen FC; Skarphedinsson S; Dessau RB
    Ugeskr Laeger; 2017 May; 179(18):. PubMed ID: 28473022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial.
    Stupica D; Collinet-Adler S; Blagus R; Gomišček A; Cerar Kišek T; Ružić-Sabljić E; Velušček M
    Lancet Infect Dis; 2023 Mar; 23(3):371-379. PubMed ID: 36209759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First-choice treatment for erythema migrans is still penicillin].
    Eliassen KE; Lindbaek M; Berild D; Hjortdahl P; Fetveit A
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1681; author reply 1681. PubMed ID: 18704139
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis.
    Egberts F; Möller M; Proksch E; Schwarz T
    J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in southern Sweden.
    Ornstein K; Berglund J; Nilsson I; Norrby R; Bergström S
    J Clin Microbiol; 2001 Apr; 39(4):1294-8. PubMed ID: 11283044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment failure in erythema migrans--a review.
    Weber K
    Infection; 1996; 24(1):73-5. PubMed ID: 8852475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.
    Smith RP; Schoen RT; Rahn DW; Sikand VK; Nowakowski J; Parenti DL; Holman MS; Persing DH; Steere AC
    Ann Intern Med; 2002 Mar; 136(6):421-8. PubMed ID: 11900494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of Lyme borreliosis.
    Aberer E; Klade H
    Infection; 1991; 19(4):284-6. PubMed ID: 1917047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of Lyme borreliosis in children.
    Krbkova L; Stanek G
    Infection; 1996; 24(2):170-3. PubMed ID: 8740116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
    Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
    Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.